Topic · page 30 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,161–1,200 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

J Am Coll Cardiol18 Mar 2025
Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study
Cohort study
J Am Coll Cardiol17 Mar 2025
Impact of Heart Failure Severity on Vutrisiran Efficacy in Transthyretin Amyloidosis With Cardiomyopathy
Secondary analysis
Circulation17 Mar 2025
Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction
Cohort study
Eur J Heart Fail17 Mar 2025
How to Handle Polypharmacy in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC
Guideline or statement
Eur J Heart Fail17 Mar 2025
Factors Associated with the Use of Guideline-Directed Medical Therapy in Patients with Left Ventricular Assist Device
Cohort study
JACC Heart Fail12 Mar 2025
Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy
Cohort study
JACC Heart Fail12 Mar 2025
Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF
Meta-analysis
JACC Heart Fail12 Mar 2025
Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin: An Exploratory Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial
Secondary analysis
JACC Heart Fail12 Mar 2025
Stroke in Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis of Randomized Trials
Meta-analysis
JACC Heart Fail12 Mar 2025
Glucagon-Like Peptide 1 Receptor Agonist Is Associated With Improved Survival in Overweight Heart Failure Patients
Cohort study
JACC CardioOncol12 Mar 2025
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis
Cohort study
Eur J Heart Fail12 Mar 2025
Quality of Life in Heart Failure. The Heart of the Matter. A Scientific Statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
Guideline or statement
Eur J Prev Cardiol12 Mar 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
Guideline or statement
Eur J Heart Fail10 Mar 2025
Association of Clonal Haematopoiesis with Heart Failure Incidence and Outcomes: A Systematic Review and Meta-Analysis
Meta-analysis
Circulation7 Mar 2025
Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry
Cohort study
Eur J Prev Cardiol6 Mar 2025
Impact of sodium–glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis
Meta-analysis
JACC Heart Fail5 Mar 2025
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial
Randomised controlled trial
JACC Heart Fail5 Mar 2025
Severe Heart Failure and Treatment With Dapagliflozin Across the Ejection Fraction Spectrum: DAPA-HF and DELIVER
Secondary analysis
Eur J Heart Fail2 Mar 2025
Kidney Status and Events Preceding Death in Heart Failure: A Real-World Nationwide Study
Cohort study
JAMA Cardiol1 Mar 2025
Angiotensin Receptor-Neprilysin Inhibitor Prescribing Patterns in Patients Hospitalized for Heart Failure
Cross-sectional study
JAMA Cardiol1 Mar 2025
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial
Secondary analysis
JAMA Cardiol1 Mar 2025
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
Randomised controlled trial
Eur J Prev Cardiol27 Feb 2025
Advanced prediction of heart failure risk in elderly diabetic and hypertensive patients using nine machine learning models and novel composite indices: insights from NHANES 2003–2016
Cross-sectional study
Eur J Heart Fail27 Feb 2025
Urinary Sodium Analysis: The Key to Effective Diuretic Titration? European Journal of Heart Failure Expert Consensus Document
Guideline or statement
JAMA Cardiol26 Feb 2025
Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial
Secondary analysis
Eur J Heart Fail26 Feb 2025
Clinical Management and Therapeutic Optimization of Patients with Heart Failure with Reduced Ejection Fraction and Low Blood Pressure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC
Guideline or statement
Eur Heart J26 Feb 2025
Tafamidis in octogenarians with wild-type transthyretin cardiac amyloidosis: an international cohort study
Cohort study
Eur Heart J25 Feb 2025
Metabolic flexibility and reverse remodelling of the failing human heart
Mechanistic study
J Am Coll Cardiol25 Feb 2025
Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel
Research article
J Am Coll Cardiol25 Feb 2025
Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure: JACC Expert Panel From the HF-ARC
Guideline or statement
JACC Cardiovasc Interv24 Feb 2025
Microvascular Resistance Reserve and Prognosis After Heart Transplantation
Cohort study
JACC Cardiovasc Imaging21 Feb 2025
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum
Research article
Eur J Prev Cardiol19 Feb 2025
Association of pre-admission exercise habit with post-discharge outcomes for older patients with heart failure
Secondary analysis
Eur J Prev Cardiol19 Feb 2025
Global prevalence of myocardial fibrosis among individuals with cardiometabolic conditions: a systematic review and meta-analysis
Meta-analysis
Eur J Heart Fail19 Feb 2025
Skeletal Muscle and Subcutaneous Fat Quantity as Prognostic Indicators in Cardiac Amyloidosis
Cohort study
Eur Heart J12 Feb 2025
Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry
Secondary analysis
Eur Heart J12 Feb 2025
Suspected de novo heart failure in outpatient care: the REVOLUTION HF study
Cohort study
Eur J Heart Fail11 Feb 2025
Salt Repletion and Diuretic Response: The Role of Serum Chloride. A Post-hoc Analysis of the SALT-HF Trial on Furosemide and Hypertonic Saline Solution Administration in Ambulatory Patients with Worsening Heart Failure
Secondary analysis
JACC CardioOncol11 Feb 2025
A Multicenter Study of Contemporary Long-Term Tafamidis Outcomes in Transthyretin Amyloid Cardiomyopathy
Cohort study
Eur J Heart Fail11 Feb 2025
Comorbidity Trajectories Before and After the Diagnosis of Heart Failure: A UK Biobank Cohort Study
Cohort study

All 1,928 Briefs in ExploreShowing Briefs 1,161–1,200 of 1,928, newest first